Dr Amy Wyrzykowski, MD | |
315 Boulevard Ne, Suite 500, Altanta, GA 30312 | |
(404) 265-3635 | |
(404) 265-3634 |
Full Name | Dr Amy Wyrzykowski |
---|---|
Gender | Female |
Speciality | General Surgery |
Experience | 26 Years |
Location | 315 Boulevard Ne, Altanta, Georgia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841360625 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 047871 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Beth Israel Deaconess Medical Center | Boston, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc | 4486567104 | 1344 |
News Archive
A common molecular pathway could help physicians predict which lung cancer patients will benefit from chemotherapy drugs, according to new research from a multidisciplinary team at the University of Cincinnati (UC).
Precisely targeted radiation therapy can eradicate all evidence of disease in selected patients with cancer that has spread to only a few sites, suggests the first published report from an ongoing clinical trial.
Phadia today announced that it has entered into an agreement to acquire 100 per cent of the shares in the Chinese marketing company WKL from the parent company MeiRui. The acquisition is made through AllergonAB, a wholly owned subsidiary of Phadia, and is subject to approval by Chinese authorities.
Einstein once observed that "it is harder to crack prejudice than an atom". If he was right, then Hans Rosling is faced with a labour of Hercules.
Human lung tumors have the ability to eliminate Vitamin D, a hormone with anti-cancer activity, a new study from the University of Pittsburgh Cancer Institute (UPCI) suggests.
› Verified 6 days ago
Entity Name | Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720037385 PECOS PAC ID: 4486567104 Enrollment ID: O20031203000426 |
News Archive
A common molecular pathway could help physicians predict which lung cancer patients will benefit from chemotherapy drugs, according to new research from a multidisciplinary team at the University of Cincinnati (UC).
Precisely targeted radiation therapy can eradicate all evidence of disease in selected patients with cancer that has spread to only a few sites, suggests the first published report from an ongoing clinical trial.
Phadia today announced that it has entered into an agreement to acquire 100 per cent of the shares in the Chinese marketing company WKL from the parent company MeiRui. The acquisition is made through AllergonAB, a wholly owned subsidiary of Phadia, and is subject to approval by Chinese authorities.
Einstein once observed that "it is harder to crack prejudice than an atom". If he was right, then Hans Rosling is faced with a labour of Hercules.
Human lung tumors have the ability to eliminate Vitamin D, a hormone with anti-cancer activity, a new study from the University of Pittsburgh Cancer Institute (UPCI) suggests.
› Verified 6 days ago
Entity Name | Beth Israel Deaconess Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548202641 PECOS PAC ID: 8123936119 Enrollment ID: O20041001000827 |
News Archive
A common molecular pathway could help physicians predict which lung cancer patients will benefit from chemotherapy drugs, according to new research from a multidisciplinary team at the University of Cincinnati (UC).
Precisely targeted radiation therapy can eradicate all evidence of disease in selected patients with cancer that has spread to only a few sites, suggests the first published report from an ongoing clinical trial.
Phadia today announced that it has entered into an agreement to acquire 100 per cent of the shares in the Chinese marketing company WKL from the parent company MeiRui. The acquisition is made through AllergonAB, a wholly owned subsidiary of Phadia, and is subject to approval by Chinese authorities.
Einstein once observed that "it is harder to crack prejudice than an atom". If he was right, then Hans Rosling is faced with a labour of Hercules.
Human lung tumors have the ability to eliminate Vitamin D, a hormone with anti-cancer activity, a new study from the University of Pittsburgh Cancer Institute (UPCI) suggests.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Amy Wyrzykowski, MD 805 Sandy Plains Road, Medical Staff Services, Marietta, GA 30066-6340 Ph: () - | Dr Amy Wyrzykowski, MD 315 Boulevard Ne, Suite 500, Altanta, GA 30312 Ph: (404) 265-3635 |
News Archive
A common molecular pathway could help physicians predict which lung cancer patients will benefit from chemotherapy drugs, according to new research from a multidisciplinary team at the University of Cincinnati (UC).
Precisely targeted radiation therapy can eradicate all evidence of disease in selected patients with cancer that has spread to only a few sites, suggests the first published report from an ongoing clinical trial.
Phadia today announced that it has entered into an agreement to acquire 100 per cent of the shares in the Chinese marketing company WKL from the parent company MeiRui. The acquisition is made through AllergonAB, a wholly owned subsidiary of Phadia, and is subject to approval by Chinese authorities.
Einstein once observed that "it is harder to crack prejudice than an atom". If he was right, then Hans Rosling is faced with a labour of Hercules.
Human lung tumors have the ability to eliminate Vitamin D, a hormone with anti-cancer activity, a new study from the University of Pittsburgh Cancer Institute (UPCI) suggests.
› Verified 6 days ago